GE HealthCare Technologies (GEHC) Cost of Revenue (2022 - 2026)

GE HealthCare Technologies' Cost of Revenue history runs 5 years deep, the most recent figure standing at $481.0 million for Q1 2026.

• Quarterly Cost of Revenue changed 0.0% year-over-year to $481.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 billion (up 252.83% YoY) and the FY2025 annual result came in at $1.5 billion, down 24.87% from the prior year.
• Cost of Revenue was $481.0 million for Q1 2026 at GE HealthCare Technologies, up from -$440.0 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $6.1 billion in Q4 2023 and bottomed at -$4.1 billion in Q4 2024.
• A 5-year average of $1.0 billion and a median of $751.0 million in 2022 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2023 — Cost of Revenue soared 4213.48% — and 2024, when it plunged 167.66%.
• GE HealthCare Technologies' Cost of Revenue stood at $141.0 million in 2022, then surged by 4213.48% to $6.1 billion in 2023, then plunged by 167.66% to -$4.1 billion in 2024, then jumped by 89.31% to -$440.0 million in 2025, then soared by 209.32% to $481.0 million in 2026.
• Business Quant data shows GEHC's Cost of Revenue at $481.0 million in Q1 2026, -$440.0 million in Q4 2025, and $2.3 billion in Q3 2025.